SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shelter Pharma informs about receipt of order

04 Jun 2024 Evaluate
Pursuant to regulation 30(4) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, Shelter Pharma has informed that Shelter Pharma secured a noteworthy order from Genet International for the product of Lactocal Gel 5 Ltr x 2000 pcs and 10 Ltr x 500 pcs, Utron Plus 500 ml x 2000 pcs, Pee Bloat 100 ml x 2000 pcs, Livodin Powder 25 Kg x 100pcs, Total Order worth Rupees 8.68 lakhs ($10,450) approximately. The details of the order as per SEBI is been annexed this letter. 

The above information is a part of company’s filings submitted to BSE.

Shelter Pharma Share Price

32.36 0.56 (1.76%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×